Multiple Sclerosis Clinical Trial
Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis
Summary
The primary objective is to evaluate the feasibility of the Multiple Sclerosis Performance Test (MSPT) in a clinical care setting when used by participants with Multiple Sclerosis (MS).
Eligibility Criteria
Key Inclusion Criteria:
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use confidential health information in accordance with applicable participant privacy regulations
Diagnosis of MS, including Clinically Isolated Syndrome
Ability to understand the audio and visual instructions for the test modules
Visual function, based on the investigator's clinical judgement that does not preclude an ability to interact with the Multiple Sclerosis Performance Test (MSPT).
Key Exclusion Criteria:
Unable or unwilling to provide informed consent
Participants younger than 18 years of age, unless their parent or legal guardian provides the required signed and dated informed consent and authorization to use confidential health information and the participant provides assent in accordance with national and local subject privacy regulations
NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 33 Locations for this study
Berkeley California, 94705, United States
Los Angeles California, 90033, United States
Aurora Colorado, 80045, United States
Washington District of Columbia, 20007, United States
Atlanta Georgia, 30309, United States
Atlanta Georgia, 30327, United States
Chicago Illinois, 60008, United States
Boston Massachusetts, 02215, United States
Farmington Hills Michigan, 48334, United States
Owosso Michigan, 48867, United States
Saint Louis Missouri, 63131, United States
Teaneck New Jersey, 07666, United States
Buffalo New York, 14202, United States
Durham North Carolina, 27710, United States
Oklahoma City Oklahoma, 73104, United States
Portland Oregon, 97225, United States
Philadelphia Pennsylvania, 19104, United States
Pittsburgh Pennsylvania, 15212, United States
Dallas Texas, 75390, United States
Salt Lake City Utah, 84103, United States
Seattle Washington, 98122, United States
Spokane Washington, 99208, United States
Prague , 12000, Czechia
Strasbourg , 67200, France
Bari , 70124, Italy
Catania , 95123, Italy
Milano , 20132, Italy
Orbassano , 10043, Italy
Roma , 00185, Italy
Basel , 4031, Switzerland
Bern , 3010, Switzerland
Camberley , GU16 , United Kingdom
Oxford , OX3 9, United Kingdom
How clear is this clinincal trial information?